Filing Flows

Filing Flows › Regenerative Medical Technology Group (RMTG) › How it makes money

How Regenerative Medical Technology Group (RMTG) makes money

Regenerative Medical Technology Group (RMTG) made $4.0M of revenue in the second quarter 2026 (Q2 2026), +309% from a year earlier.

Drawing the Sankey…

Regenerative Medical Technology Group: revenue by line, Q4 2024 to Q1 2026Regenerative Medical Technology Group: revenue by line, Q4 2024 to Q1 2026Product SuppliesPatient ProceduresTrainingEquipmentsProduct Supplies: $1.3M latest$1.3MPatient Procedures: $600K latest$600KTraining: $772K latest$772KEquipments: $0 latestQ4 2024Q1 2025Q4 2025Q1 2026
Product Supplies went from 34% of revenue in Q4 2024 to 48% in Q1 2026, the largest shift in the mix.
Regenerative Medical Technology Group revenue by quarterRegenerative Medical Technology Group revenue by quarter$1.5MQ4 2024$1.4MQ1 2025$983KQ2 2025$1.2MQ3 2025$1.6MQ4 2025$2.6MQ1 2026$4.0MQ2 2026
Regenerative Medical Technology Group: where each dollar of revenue goesRegenerative Medical Technology Group: where each dollar of revenue goesOperating cash flow8¢Free cash flow7¢

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$4.0M100.0%
Operating cash flow$332K8.3%
Free cash flow$288K7.2%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$4.0M+309%
Q1 2026$2.6M+94%
Q4 2025$1.6M+4%
Q3 2025$1.2M+20%
Q2 2025$983K+24%
Q1 2025$1.4M+67%
Q4 2024$1.5M+145%

From Regenerative Medical Technology Group's 10-Q filed Aug 19, 2026 (on EDGAR).

Questions

How does Regenerative Medical Technology Group make money?

Regenerative Medical Technology Group (RMTG) made $4.0M of revenue in the second quarter 2026 (Q2 2026), +309% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.